Chinese API Maker Cited Over Data Integrity in FDA Warning Letter

Drug Industry Daily
A A
A Chinese API maker relied on manipulated data and incomplete records to make decisions on batch releases, prompting the FDA to issue a warning letter to the company over data integrity.

To View This Article:

Login

Subscribe To Drug Industry Daily